Procore CLO sells 3,942 shares at $50 each
Procore Technologies Chief Legal Officer Benjamin C. Singer reported an open-market sale of company stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Procore Technologies Chief Legal Officer Benjamin C. Singer reported an open-market sale of company stock. On May 29, 2026, he sold 3,942 shares of Procore common stock at $50.00 per share.
The filing states that this transaction was made under a pre-arranged Rule 10b5-1 trading plan dated August 13, 2025, indicating it was scheduled in advance. After the sale, Singer still directly owns 96,723 shares of Procore common stock, so the sale reflects only a small portion of his overall holdings.
Insights
Pre-planned, modest insider sale with large remaining stake.
The reporting shows Chief Legal Officer Benjamin C. Singer executed an open-market sale of 3,942 shares of Procore common stock at $50.00 per share. This is classified as a straightforward sale of non-derivative shares, not tied to option exercises.
A key detail is the footnote that the sale occurred under a Rule 10b5-1 trading plan dated August 13, 2025, suggesting the trade was pre-scheduled rather than opportunistic. After the transaction, Singer still holds 96,723 shares, so the sale represents a relatively small fraction of his position visible in this filing.
For investors, this looks like routine portfolio management by a senior executive rather than a shift in sentiment. The absence of derivative positions in the derivative summary reinforces that no options or similar instruments were exercised or altered here.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 3,942 | $50.00 | $197K |
Footnotes (1)
- F1. Shares sold pursuant to a 10b5-1 plan dated August 13, 2025.
Key Figures
Key Terms
Rule 10b5-1 regulatory
open-market sale financial
Common Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Procore (PCOR) disclose for Benjamin C. Singer?
Was Benjamin C. Singer’s Procore (PCOR) stock sale made under a 10b5-1 plan?
What role does Benjamin C. Singer hold at Procore (PCOR)?
AI-generated analysis. How Rhea-AI works. Not financial advice.